Physician

Anjali Vaidya, MD

According to 2025 Medicare claims, Anjali Vaidya, MD (NPI: 1902969371) practices advanced heart failure and transplant cardiology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN INC (NPI: 1457833485; TIN: 831002191) and primary practice location at 19140-5103.

Vaidya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 737 traditional Medicare patients, billed 1,620 HCPCS/CPT codes, and received $26,076 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,545 prescription claims across 90 beneficiaries totaling $14,546,163 in drug costs, led by Opsumit (Macitentan). DME data shows 117 claims. Open Payments data shows 177 records totaling $133,021. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $90,839 to $26,076. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,358,194 to $14,546,163. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $8,572 and ending at $9,642.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	299	1,316	$90,839
2016	219	856	$59,621
2017	192	645	$59,539
2018	177	614	$78,589
2019	182	590	$57,513
2020	93	169	$20,743
2021	91	231	$30,364
2022	103	196	$19,292
2023	841	1,806	$33,065
2024	737	1,620	$26,076

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	99	597	$1,358,194
2016	116	945	$2,109,927
2017	89	701	$2,691,162
2018	93	1,149	$5,702,748
2019	104	1,403	$7,092,648
2020	101	1,587	$9,190,798
2021	100	1,472	$9,352,633
2022	85	1,235	$8,818,492
2023	90	1,367	$11,543,829
2024	90	1,545	$14,546,163

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	138	$429,947
2016	N/R	176	$74,919
2017	N/R	143	$120,161
2018	N/R	142	$172,609
2019	N/R	122	$176,103
2020	N/R	159	$511,741
2021	N/R	220	$778,874
2022	N/R	211	$473,828
2023	N/R	164	$529,516
2024	N/R	117	$222,945

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	19	19	$140
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	42	65	$115
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	52	75	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	37	48	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	674	1,362	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Opsumit	Macitentan	347	10,360	$4,397,969
Adempas	Riociguat	276	8,190	$3,767,104
Orenitram Er	Treprostinil Diolamine	97	2,910	$2,077,072
Uptravi	Selexipag	67	1,978	$1,560,838
Tyvaso Dpi	Treprostinil	61	1,708	$1,430,081

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J3285	Injection, treprostinil, 1 mg	N	N/R	23	$213,501
K0455	Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)	Y	N/R	23	$5,345
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	27	$1,699
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	21	$1,617
E1392	Portable oxygen concentrator, rental	Y	N/R	23	$784

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	176	$131,697	Actelion Pharmaceuticals US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$1,324	Bayer Healthcare Pharmaceuticals Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anjali Vaidya, MD?

Tedicare shows public-source Medicare data for Anjali Vaidya, MD (NPI 1902969371), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anjali Vaidya, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anjali Vaidya, MD?

Anjali Vaidya, MD is linked to TEMPLE FACULTY PRACTICE PLAN INC (billing NPI 1457833485) in the available physician profile data.

Does Anjali Vaidya, MD have Open Payments data?

Anjali Vaidya, MD has 177 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.